Appeals Court Rehearing Rejected In Teva-GSK Skinny-Label Saga
Split Federal Circuit Refuses ‘En Banc’ Rehearing Of Labeling Carve-Out Case
Teva will not get a third hearing at the US Court of Appeals for the Federal Circuit in its long-running dispute with GSK over skinny-label generics, after the appeals court rejected a petition for the full bench to re-examine the case.
